Corcept Therapeutics Inc - ESG Rating & Company Profile powered by AI
The article contains a questions and answers table for Corcept Therapeutics Inc. Check the end of the page for potential risks for Corcept Therapeutics Inc based on industry, location and size. If you work at Corcept Therapeutics Inc and you would like to use your Sustainability aseessment, please get in touch.
Corcept Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.2; made up of an environmental score of 1.1, social score of 3.0 and governance score of 5.0.
3.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1705 | Prothena Corporation PLC | 3.3 | Medium |
| 1705 | Withus Pharmaceutical Co Ltd | 3.3 | Medium |
| 1733 | Corcept Therapeutics Inc | 3.2 | Medium |
| 1733 | AcuCort AB | 3.2 | Medium |
| 1733 | Acura Pharmaceuticals Inc | 3.2 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Corcept Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Corcept Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Corcept Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Corcept Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Corcept Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Corcept Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Corcept Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Corcept Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Corcept Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Corcept Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Corcept Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Corcept Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Corcept Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Corcept Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Corcept Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Corcept Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Corcept Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Corcept Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.